Publications with BNE Acknowledgement



Aho L, Pikkarainen M, Hiltunen M, Kuusisto E, Leinonen V, Alafuzoff I (2010). JAD. Immunohistochemical visualisation of intracellular amyloid precursor protein and β-amyloid in the human brain. (in press)

Martins-de-Souza D, Dias-Neto E, Schmitt A, Falkai P, Gormanns P, Maccarrone G, Turck CW, Gattaz WF (2010). Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry. Mar;11(2):110-20.

Martins-de-Souza D, Maccarrone G, Wobrock T, Zerr I, Gormanns P, Reckow S, Lebar M, Falkai P, Schmitt A, Turck CW (2010): Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers for schizophrenia. Journal of Neuroscience submitted.

Martins-de-Souza D, Wobrock T, Zerr I, Schmitt A, Falkai P, Turck CW (2010). Apolipoprotein E and prostaglandin-H2 D-isomerase proteins found altered in schizophrenia cerebrospinal fluid using a simple proteomic method. World Journal of Biological Psychiatry submitted.

Parlapani E, Schmitt A, Wirths O, Bauer M, Sommer C, Skowronek M, Treutlein J, Petroianu G, Rietschel M, Falkai P (2010). Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. World J Biol Psychiatry. Mar;11(2 Pt 2):243-50.

Pikkarainen M, Martikainen P, Alafuzoff I (2010). The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol. 2010 Jan;69(1):40-52.

Poulter MO, Du L, Zhurov V, Palkovits M, Faludi G, Merali Z and Anisman H (2010). Altered organization of GABAA receptor mRNA expression in the depressed suicide brain. Frontiers in Molecular Neuroscience, March 2010, Volume 3, Article 3, 1.

Schmitt A, Koschel J, Zink M, Bauer M, Sommer C, Skowronek M, Treutlein J, Schulze T, Schneider-Axmann T, Parlapani E, Rietschel M, Falkai P, Henn FA (2010). Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. Mar;260(2):101-11.

Sommer WH, Lidström J, Sun H, Passer D, Eskay R, Parker SCJ, Witt S, Zimmermann U, Nieratschker Vanessa, Rietschel M, Margulies EH, Palkovits M, Laucht M and Heilig M (2010). Human NPY Promoter Variation rs16147:T>C as a Moderator of Prefrontal NPY Gene Expression and Negative Affect. Human Mutation (in press).

Terni B, Boada J, Portero-Otin M, Pamplona R, Ferrer I (2010). Mitochondrial ATP synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer disease pathology. Brain Pathol 20: 222-233.

top top


Bagó AG, Dimitrov E, Saunders R, Seress L, Palkovits M, Usdin TB, Dobolyi A (2009). Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162: 128-147.

Balázsa T, Dobolyi A, Kovács Zs, Palkovits M (2009). Effects of post-mortem delay on protein levels in human brain samples. Front Syst Neurosci, doi: 10.3389/conf.neuro.01.2009.04.251

Barrachina M, Ferrer I (2009). DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J Neuropathol Exp Neurol 68: 880-891.

Clarimón J, Molina-Porcel L, Gómez-Isla T, Blesa R, Guardia-Laguarta C, González-Neira A, Estorch M, Ma Grau J, Barraquer L, Roig C, Ferrer I, Lleó A (2009). Early-Onset Familial Lewy Body Dementia with Extensive Tauopathy: A Clinical, Genetic, and Neuropathological Study. J Neuropathol Exp Neurol 68: 73-82.

Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff G, Schmitt A, Bogerts B, Bernstein HG (2009). Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World Journal of Biological Psychiatry in press.

Ferrer I (2009). Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer’s disease. J Bioenerg Biomembr 41: 425-431.

Ferrer I (2009). Early involvement of the cerebral cortex in Parkinson’s disease: Convergence of multiple metabolic defects. Progr Neurobiol 88: 89-103

Gomez A, Ferrer I (2009). Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases. J Neurosci Res 87: 1002-1013.

Habl G, Zink M, Petroianu G, Bauer M, Schneider-Axmann T, Falkai P, Henn FA, Schmitt A (2009). Increased D-amino acid oxidase (DAAO) expression in the bilateral hippocampus of schizophrenia patients: a post-mortem study. Journal of Neural Transmission 116: 1657-1665

Héja L, Barabás P, Nyitrai G, Kékesi KA, Lasztóczi B, Tőke O, Tárkányi G, Madsen K, Schousboe A, Dobolyi Á, Palkovits M, Kardos J (2009). Glutamate uptake triggers transporter-mediated GABA release from astrocytes. PloS One 4/e, 7153:1-12, doi:10.1371

Ironside, J. Straight talk with..….James Ironside. (Interviewed by Jon Evans) (2009) Nat. Med 15(8): 834-5.

Kékesi A, Simor A, Balogh B, Czurkó A, Gulyás EH, Medzihradszky K, Palkovits M, Juhász G (2009). Proteomic analysis of the suicide brain. Front Syst Neurosci, doi: 10.3389/conf.neuro.01.2009.04.094

Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, Budka H, Ghetti B, Spina S (2009). TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord. 24:1843-7. IF: 3,898

Kretzschmar H (2009). Brain banking: opportunities, challenges and meaning for the future. Nat Rev Neurosci. 10(1):70-8.

Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarone G, Hunyadi-Gulyas E, Marangoni S, Turck C, Novello JC, Dias-Neto E (2009). Proteomics analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatric Research 43 (11): 978-986.

Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Dias-Neto E (2009). Proteome analysis of schizophrenia patients Wernicke’s area reveals an energy metabolism dysregulation. BMC Psychiatry Apr 30;9(1):17.

Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarone G, Dias-Neto E, Turck CW (2009). Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 259 (3): 151-163.

Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, Maccarone G, Turck CW, Dias-Neto E (2009). Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. Journal of Neural Transmission 116 (3): 275-289

Martins-de-Souza D, Maccarone G, Reckow S, Falkai P, Schmitt A, Turck CW (2009). Shotgun mass spectrometry analysis of the human thalamus proteome. Journal of Separation Science 32(8):1231-6.

Navarro A, Boveris A, Bández MJ, Sanchez-Pinto MJ, Gómez C, Muntane G, Ferrer I (2009). Human brain cortex: mitochondrial oxidative damage and adaptative response in Parkinson disease and dementia with Lewy bodies. Free Radic Biol Med 46: 1574-1580.

Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I (2009). Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol 118: 497-504.

Santpere G, Ferrer I (2009). Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation. Brain Pathol 19: 177-187.

Santpere G, Ferrer I (2009). LRRK2 and neurodegeneration. Acta Neuropathol 117: 227-246.

top top


Aho L, Parkkinen L, Pirttilä T, Alafuzoff I (2008). Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects, Dementia and geriatric. Cognitive disorders 25:423-432.

Alafuzoff I, Aho L, Helisalmi S, Mannermaa A, Soininen H (2009). b-amyloid deposition in brains in subjects with diabetes. Neuropathol Appl Neurobiol. Feb;35(1):60-8. Epub 2008 Mar 10.

Albasanz JL, Perez S, Barrachina M, Ferrer I, Martin M (2008). Up-regulation of adenosine receptors in the frontal cortex in Alzheimer’s disease. Brain Pathol 18: 211-219.

Anisman H, Du L, Palkovits M, Faludi G, Kovacs GG, Szontagh-Kishazi P, Merali Z & Poulter MO (2008). Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 33: 131-141.

Aoki M, Volkmann I, Tjernberg LO, Winblad B, Bogdanovic N (2008). Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain. Neuroreport. 19(11):1085-9.

Bagó AG, Palkovits, M, Usdin TB, Seress L & Dobolyi Á (2008). Evidence for the expression of parathyroid hormone 2 receptor in the human brainstem. Clin Neurosci/Ideggyógy Sz 61: 123-126.

Beyer K, Domingo-Sabat M, Lao JI, Carrato C, Ferrer I, Ariza A (2008). Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases. Neurogenetics 9: 15-23.

Crecelius A, Götz A, Arzberger T, Fröhlich T, Arnold GJ, Ferrer I, Kretzschmar H (2008). Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE. Proteomics 8(6):1276-91.

Dalfo E, Ferrer I (2008). Early-alpha-synuclein lipoxidation in neocortex in Lewy body diseases. Neurobiol Aging 29: 408-417.

De Mota N, iturrioz X, Claperon C, Bodineau L, Fassot C, Roques BP, Palkovits M & Llorens-Cortes C (2008). Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei. J Neurochemistry 106: 416-428.

Ferrer I, Santpere G, van Leeuwen FW (2008). Argyrophilic grain disease. Brain 131: 1416-1432.

Giaccone G, Marcon G, Mangieri M, Morbin M, Merlin M, Fetoni V, Patriarca C, Catania M, Di Fede G, Tagliavini F (2008). Atypical tauopathy with massive involvement of the white matter. Neuropathology Applied Neurobiology, 34:468-472

Kovacs GG, Kovári V, Nagy Z (2008). Frequency of different forms of dementia at the Department of Neuropathology of the Hungarian National Institute of Psychiatry and Neurology during a 3-year period. Ideggyogy Sz. 61:24-32. Hungarian.

Kovacs GG, Majtenyi K, Spina S, Murrell JR, Gelpi E, Hoftberger R, Fraser G, Crowther RA, Goedert M, Budka H, Ghetti B (2008). White matter tauopathy with globular glial inclusions: a distinct entity of sporadic frontotemporal lobar degeneration. J Neuropath Exp Neurol;67:963-75. IF: 5,14

Kovacs GG, Milenkovic IJ, Preusser M, Budka H (2008). Nigral burden of alpha-synuclein correlates with striatal dopamine deficit. Mov Disord.; 23:1608-12.IF: 3,898

Kovacs GG, Pittman A, Revesz T, Luk C, Lees A, Kiss E, Tariska P, Laszlo L, Molnár K, Molnar MJ, Tolnay M, de Silva R (2008). MAPT S305I mutation: implications for argyrophilic grain disease. Acta Neuropathol. 116:103-18. IF: 5,31

Kozicz T, Tilburg-Ouwens D, Faludi G, Palkovits M & Roubos E (2008). Gender-related urocortin 1 and brain-derived neurotropic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience 152: 1015-1023.

Kuusisto E, Kauppinen T, Alafuzoff I (2008). Use of p62 / SQSTM1 antibodies for neuropathological diagnosis. Neurobiol Appl Neuropath:34:169-180.

LeMaitre E, Diaz-Heijtz R, Palkovits M, Hökfelt T (2008). The galanin system in the human locus coeruleus and dorsal raphe neurons. J Neural Transm 115: 1724-1725.

Martinez A, Dalfo E, Muntane G, Ferrer I (2008). Glycoplytic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy. J Neural Transm 115: 59-66.

Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarone G, Dias-Neto E, Turck CW (2008). Proteome of human dorsolateral prefrontal cortex using shotgun mass spectrometry. Journal of Separation Science Sep 31 (16-17): 3122-3126.

Molnár T, Barabás P, Héja L, Kútiné Fekete E, Lasztóczi B, Szabó P, Nyitrai G, Simon-Trompler E, Hajós F, Palkovits M & Kardos J (2008). g-Hydroxybutyrate binds to the synaptic site recognizing succinate monocarboxylate: A new hypothesis on astrocyte–neuron interaction via the protonation of buccinate. J Neurosci Res 86: 1566-1576.

Muntane G, Dalfo E, Martinez A, Ferrer I (2008). Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related alpha-synucleinopathies. Neuroscience 152: 913-923.

Palkovits M, Harvey-White J, Liu J, Kovacs Zs, Bobest M, Lovas G, Bagó AG & Kunos G (2008). Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. Neuroscience 152: 1032-1039.

Pamplona R, Ilievas K, Ayala V, Bellmunt MJ, Cacabelos D, Dalfo E, Ferrer I (2008). Portero-Otin MMaillard reaction versus other nonenzymatic modifications in neurodegenerative processes. Ann NY Acad Sci 1126: 315-319.

Pikkarainen M, Hartikainen P, Alafuzoff I (2008). Neuropathological features in frontotemporal lobar degeneration with ubiquitin only pathology when visualized by p62 immunohistochemistry. J Neuropathol Exp Neurol. Apr;67(4):280-98.

Poulter MO, Du L, Weaver ICG, Palkovits M, Faludi G, Merali Z, Szyf M, Anisman H (2008). GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry, 64: 645-652.

Santamaria I, Santpere G, MacDonald MJ, Gomez de Barreda E, Hernandez GF, Moreno FJ, Ferrer I, Avila J (2008). Coenzyme Q induces tau aggregation, tau filament, and Hirano bodies. J Neuropathol Exp Neurol 67: 428-434.

Schmidt M, Monoranu C, Riederer P et al. (2008). Qualtiy control of human post mortem brain tissue: pH measurement useful as quality marker? Clinical Neuropathology. 27(3): 150.

Schmitt A, Parlapani E, Bauer M, Heinsen H, Falkai P (2008): Is brain banking of psychiatric cases valuable for neurobiological research? Clinics 63 (2): 255-266.

Schmitt A, Parlapani E, Gruber O, Wobrock T, Falkai P (2008). Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. European Archives of Psychiatry and Clinical Neuroscience 258, Suppl 5: 35-39

Schmitt A, Steyskal C, Bernstein HG, Parlapani E, Schaeffer E, Gattaz WF, Bogerts B, Schmitz C, Falkai P (2008). A stereological investigation of posterior hippocampal subregions in schizophrenia. Acta Neuropathologica submitted 117 (4): 395-407.

Smalla KH, Mikhaylova M, Sahin J, Bernstein HG, Bogerts B, Schmitt A, van der Schors R, Smit AB, Li KW, Gundelfinger ED, Kreutz M (2008). A comparison of the synaptic proteome in human schizophrenia and rat ketamine psychosis suggest that Prohibitin is involved in the synaptic pathology of schizophrenia. Mol Psychiatry 13 (9): 878-896

Sorolla A, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E (2008). Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med. 2008 Sep 1;45(5):667-78.

top top


Dehvari N, Cedazo-Minguez A, Isacsson O, Nilsson T, Winblad B, Karlström H, Benedikz E, and Cowburn RF (2007). Presenilin dependence of phospholipase C and protein kinase C signalling. J Neurochem. 102:848-57.

Ferrer I, Perez E, Dalfo E, Barrachina M (2007). Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci Lett 415: 205-209.

Gallatz K, Medveczky P, Németh P, Szilágyi L, Gráf L & Palkovits M (2007). Human trypsin(ogen) 4-like immunoreactivity in the white matter of the cerebral cortex and the spinal cord. Clin Neurosci/Ideggyógy Sz 60:118-123.

Gelpi E, Preusser M, Bauer G, Budka H (2007). Autopsy at 2 months after death: brain is satisfactorily preserved for neuropathology. Forensic Sci Int. May 24;168(2-3):177-82.

Horvath MC, Kovacs GG, Kovari V, Majtenyi K, Hurd YL, Keller E (2007).Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age. J Neurosci. 27:13371-5.

Jacob C, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P, Grünblatt E (2007). Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer’s Disease. J Alz Dis. 11(97-116).

Kovács Zs, Kékesi AK, Szilágyi N, Juhász G, Palkovits M (2007). Regional-, age- and gender-dependent differences in concentration of nucleosides in the human brain. Clin Neurosci 60(S1):35

Millar T, Walker R, Arango JC et al (2007).Tissue and Organ Donation for Research in Forensic Pathology: The MRC Sudden Death Brain and Tissue Bank. J Pathol 213:369-75.

Palkovits M (2007). Expression of neuropeptides in brain regions of depressie suicide victims. Neuropsychopharmacol Hung 9: 40-41

Parkkinen L, Hartikainen P, Alafuzoff I (2007). Abundant glial a-Synuclein pathology in a case without overt clinical symptoms. Clinical Neuropathology 26:276-283.

Perez E, Barrachina M, Rodriguez A, Torrejón-Escribano B, Boada M, Hernandez I, Sánchez M, Ferrer I (2007). Aquaporin expression in the cerebral cortex is increased at aearly stages of Alzheimer’s disease. Brain Res 1128: 164-174.

Santpere G, Puig B, Ferrer I (2007). Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer’s disease and cerebral amyloid angiopathy. Neuroscience. Jun 8;146(4):1640-51.

Sikorska B, Papierz W, Preusser M, Liberski PP, Budka H (2007). Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies. Neuropathol Appl Neurobiol 33: 126-129.

Terni B, Rey MJ, Boluda S, Torrejon-Escribano B, Sabate MP, Calopa M, van Leeuwen FW, Ferrer I (2007). Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease. Acta Neuropathol 113: 403-416.

Tóth J, Siklódi E, Medveczky P, Gallatz K, Németh P, Szilágyi L, Gráf L & Palkovits M (2007): Regional Distribution of Human Trypsinogen 4 in Human Brain at mRNA and Protein Level. Neurochem Res DOI 10.1007/s11064-007-9327-8.

top top


Albasanz JL, Rodriguez A, Ferrer I, Martin M (2006). Adenosine A2A receptors are up-regulated in Pick’s disease frontal cortex. Brain Pathol 16: 249-255 .

Barrachina M, Castano E, Dalfo E, Maes T, Buesa C, Ferrer I (2006): Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies. Neurobiol Dis 22(2):265-273.

Barrachina M, Castano E, Ferrer I (2006): TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem Int 49(3):276-284.

Barrachina M, Maes T, Buesa C, Ferrer I (2006). Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer’s disease. Neuropathol Appl Neurobiol 32: 505-516 .

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using routine sections and immunohistochmistry. Acta Neuropath:112:389-404.

Dalfo E, Martinez A, Muntane G, Ferrer I (2006): Abnormal alpha-synuclein solubility, aggregation and nitration in the frontal cortex in Pick's disease. Neurosci Lett 400(1-2):125-129.

Kauppinen T, Martikainen P, Alafuzoff I (2006). Human postmortem brain tissue and 2 mm tissue microarrays. Appl Imuunohistochem & Mol Morphol 14:353-359.

Lasn H (2006). Inferior Olivary Nucleus in Alzheimer Disease and Normal Aging. PhD theses: Published by Karolinska Institutet.

Lasn H, Winblad B and Bogdanovic N. Neuroglia in the inferior olivary nucleus during Alzheimers disease and normal aging. J Cell Mol Med, 2006, 10(1):145-56.

Martikainen P, Louhelainen AM, Kauppinen T, Alafuzoff I (2006). Human brain tissue microarray as a platform to investigate diseases of the nervous system. Brain Research:17:33-43.

Moroncini G, Mangieri M, Morbin M, Mazzoleni G, Ghetti B, Gabrielli A, Williamson RA, Giaccone G, Tagliavini F (2006). Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiology of Disease 23:717-724.

Muntane G, Dalfo E, Martinez A, Rey MJ, Avila J, Perez M, Poertero M, Pamplona R, Ayala V, Ferrer I (2006). Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick’s disease. J Neurochem 99: 177-185 .

Nilsson T, Bogdanovic N, Volkman I, Winblad B, Folkesson R, and Benedikz E (2006). Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain. Biochem Biophys Res Commun. 344:640-6.

Nilsson T, Malkiewicz K, Gabrielsson M, Folkesson R, Winblad B, and Benedikz E (2006). Antibody-bound amyloid precursor protein upregulates ornithine decarboxylase expression. Biochem Biophys Res Commun. 341:1294-9.

Riederer P, Hoyer S (2006). From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain. J Neural Transm. Nov;113(11):1671-7.

Santpere G, Puig B, Ferrer I (2006). Low molecular weight species of tau in Alzheimer's disease are dependent on tau phosphorylation sites but not on delayed post-mortem delay in tissue processing. Neurosci Lett 399(1-2):106-110.

Unterberger U, Höftberger R, Gelpi E, Flicker H, Budka H, Voigtländer T (2006). Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol 65: 348-357.

top top


Dalfo E, Albasanz JL, Rodriguez A, Martin M, Ferrer I (2005): Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease. J Neuropathol Exp Neurol 64(7):638-647.

Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Guilivi A, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E (2005). Genetic prion disease: the EUROCJD experience. Hum Genet 118: 166-174.

Parkkinen L, Pirttilä T0, Tervahauta M, Alafuzoff I (2005). Widespread and Abundant a-Synuclein Pathology in a neurologically unipaired Subject. Neuropathology:25:304-314.

top top


Copyright (c) BrainNet Europe, coordinated by the Centre for Neuropathology and Prion Research, Ludwig- Maximilians-University Munich, Germany. Tel.: +49-89-2180-78001